In our weekly check, argenx SE is graded A (A to F). Of 23 checks on debt, profit, cash flow and trend: 19 pass, warnings: 4, red flags: 0.
argenx SE is a Healthcare company (Biotechnology) based in the Netherlands, listed on NASDAQ as ARGX.
ONC · MRNA · RVMD · REGN · GMAB · ROIV
In our weekly check, argenx SE is graded A (A to F). Of 23 checks on debt, profit, cash flow and trend: 19 pass, warnings: 4, red flags: 0. The grade is a risk check, not a buy or sell recommendation.
This week's biggest flags for argenx SE: Profits not backed by cash, High P/E, Very volatile. In total 4 of 23 checks show a warning or a red flag.
argenx SE is a Healthcare company (Biotechnology) based in the Netherlands, listed on NASDAQ as ARGX.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14